Abstract
Rare diseases known as systemic vasculitides involve the inflammatory destruction of blood vessels, leading to complex disorders that can affect a single organ or multiple organs and systems. The challenges in diagnosis, coupled with the lack of awareness among healthcare providers, particularly primary care physicians, and delayed treatment, often result in disability and worsen the prognosis of systemic vasculitis patients. We have conducted a comprehensive research approach to understand the features of systemic vasculitis, considering demographic, clinical, and laboratory data in Kazakhstan (Shymkent city and the Turkestan region). This approach, which encompasses a retrospective research method, an analytical research method, and a one-stage cross-examination (online survey), is essential in our quest to improve the understanding and management of systemic vasculitis in Kazakhstan.
Publisher
South Kazakhstan Medical Academy
Reference31 articles.
1. Ralli M, Campo F, Angeletti D, Minni A, Artico M, Greco A, et al. Pathophysiology and therapy of systemic vasculitides. EXCLI J 2020;19:817-854.
2. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-192.
3. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013;65:1-11.
4. Schnabel A, Hedrich CM. Childhood vasculitis. Front Pediatr 2018;6:421.
5. Farrah TE, Basu N, Dweck M, Calcagno C, Fayad ZA, Dhaun N. Advances in therapies and imaging for systemic vasculitis. Arterioscler Thromb Vasc Biol 2019;39(8):1520-1541.